Effect of avilamycin fed to chickens on E. faecium counts and on the selection of avilamycin-resistant E. faecium populations

Microbial Drug Resistance

Volumn 11, Issue 2, 2005, Pages 170-177

  Butaye, P ^a   Devriese, L A ^b   Haesebrouck, F ^b  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AVILAMYCIN; EVERNIMICIN; GROWTH PROMOTOR;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIUM ISOLATION; CHICKEN; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; ENTEROCOCCUS FAECIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CHICKENS; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECIUM; MICROBIAL SENSITIVITY TESTS; OLIGOSACCHARIDES;

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; GALLUS GALLUS;

EID: 18944404059     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2005.11.170     Document Type: Article

References (21)

1. Aarestrup, F.M. 1998. Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomycin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin. Microb. Drug Resist. 4:137-141.
2. Aarestrup, F.M., F. Bager, N.E. Jensen, M. Madsen, A. Meyling, and H.K. Wegener. 1998. Surveillance of antimicrobial resistance in bacteria isolated from food animals to growth promoters and related therapeutic agents in Denmark. APMIS 106:606-622.
3. Aarestrup, F.M., and B. Carstensen, B. 1998. Effect of tylosin used as a growth promoter on the occurrence of macrolide-resistant enterococci and staphylococci in pigs. Microb. Drug Resist. 4:307-312.
4. Aarestrup, F.M., and L.B. Jensen. 2000. Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (avilamycin and evernimicin). Antimicrob. Agents Chemother. 44:3425-3427.
5. Aarestrup, F.M., and P.M. McNicholas. 2002. Incidence of high level evernimicin resistance in Enterococcus faecium among food animals and humans. Antimicrob. Agents Chemother. 46:3088-3090.
6. Adrian, P.V., W. Zhao, T.A. Black, K.J. Shaw, R.S. Hare, and K.P. Klugman. 2000. Mutations in ribosomal protein L16 conferring reduced susceptibility to evernimicin (SCH27899): implications for mechanism of action. Antimicrob. Agents Chemother. 44:732-738.
7. Bates, J., J.Z. Jordans, and D.T. Griffiths. 1994. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J. Antimicrob. Chemother. 34:507-514.
8. Butaye, P., L.A. Devriese, and F. Haesebrouck. 1998. Effects of different test conditions on MICs of food animal growth-promoting antibacterial agents for enterococci. J. Clin. Microbiol. 36:1907-1911.
9. Butaye, P., L.A. Devriese, and F. Haesebrouck. 1999. Enterococci with acquired vancomycin resistance in pigs and chickens of different age groups. Antimicrob. Agents Chemother. 43:365-366.
10. Butaye, P., L.A. Devriese, and F. Haesebrouck. 1999. Phenotypic distinction between Enterococcus faecium and Enterococcus faecalis strains with susceptibility and resistance to growth promoting antibiotics. Antimicrob. Agents Chemother. 43:2569-2570.
11. Butaye, P., L.A. Devriese, and F. Haesebrouck. 1999. Glycopeptide resistance in Enterococcus faecium strains from animals and humans. Rev. Med. Microbiol. 10:235-243.
12. Butaye, P., L.A. Devriese, and F. Haesebrouck. 2003. Antimicrobial growth promoters used in animal feed: effects of the less well-known antibiotics on gram-positive bacteria. Clin. Microbiol. Rev. 16:175-188.
13. Descheemaeker, P.R.M., S. Chapelle, L.A. Devriese, P. Butaye, P. Vandamme, and H. Goossens. 1999. Comparison of glycopeptide-resistant Enterococcus faecium isolates and resistance genes of human and animal origins. Antimicrob. Agents Chemother. 43:2032-2037.
14. Dutka-Malen, S., S. Evers, and P. Courvalin. 1995. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol. 33:24-27.
15. Kofoed, C.B., and B. Vester. 2002. Interaction of avilamycin with ribosomes and resistance caused by mutations in 23S rRNA. Antimicrob. Agents Chemother. 46:3339-3342.
16. Mann, P.A., L. Xiong, A.S. Mankin, A.S. Chau, C.A. Mendrick, D.J. Najarian, C.A. Cramer, D. Loebenberg, E. Coates, N.J. Murgolo, F.M. Aarestrup, R.V. Goering, T.A. Black, R.S. Hare, and P.M. Nicholas. 2001. EmtA, a rRNA methyltransferase conferring high-level evernimicin resistance. Mol. Microbiol. 41:1349-1356.
17. Robredo, B., K.V. Singh, F. Baquero, B.E. Murray, and C. Torres. 1999. From vanA Enterococcus hirae to vanA Enterococcus faecium: a study of feed supplementation with avoparcin and tylosin in young chickens. Antimicrob. Agents Chemother. 43:1137-1143.
18. Schouten, M.A., A. Voss, A.A. Hoogkamp-Korstanje, and The European VRE Study Group. 1999. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. Antimicrob. Agents Chemother. 43:2542-2546.
19. Shryock, T.R. 2001. Will avilamycin convert ziracin into zerocine? Emerg. Infect. Dis. 7:488-489.
20. Tenover, F., R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, D.H. Persing, and B. Swaminatham. 1995. Interpretation chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
21. Zarazaga, M., C. Tenorio, R. Del Campo, F. Ruiz-Larrea, and C. Torres. 2002. Mutations in ribosomal protein L16 and in 23SrRNA in Enterococcus strains for which evernimicin MICs differ. Antimicrob. Agents Chemother. 46:3657-3659.